Supreme Court Denies President Trump’s Request to Stop Selling Dangerous Abortion Pills by Mail
The U.S. Supreme Court rejected an emergency appeal Thursday to require the abortion industry to follow federal safety regulations when it sells abortion drugs to women.
The justices’ decision not to rule immediately on the Trump administration’s appeal means abortion facilities may continue to ignore Food and Drug Administration safety requirements for the abortion drug mifepristone, or Mifeprex.
No pro-life litigation will come before the Supreme Court this quarter*, however, an unresolved issue could be settled soon. The issue is the abortion pill and how to prescribe it. Unbelievable though it may seem, the ACOG (American College of Obstetricians and Gynecologists) is not opposed to women aborting themselves with pills that they order online, following online consultation, but no visit, exam, guidance or communication with a doctor in person. There are rational and serious objections to this. See here and here.
For this to be legalized, the FDA REMS (Risk Evaluation Mitigation Strategy) that requires the abortion pill to be dispensed only in clinics, must be overturned by SCOTUS.
Nevertheless, in a new development, on Sept. 30 it was reported that the Honeybee Health online pharmacy is now “distributing abortion pills directly to patients within the country by mail, now legal [ed: really?] because of a recent federal court ruling… While (District Court Judge) Judge Chuang’s ruling only extends to patients seeking care during the COVID-19 health crisis plus 30 days, and the Trump administration is appealing the injunction to the U.S. Supreme Court, this window of opportunity is proving the viability of a new model of abortion health care.”
Why wait for SCOTUS? The Rule of Law continues to be ignored by those who believe they are a law unto themselves.
*Facts change quickly. See this article for possible abortion case for SCOTUS this quarter.